Literature DB >> 27364326

Trajectory of MS disease course for men and women over three eras.

Stanley Hum1, Yves Lapierre1, Susan C Scott2, Pierre Duquette3, Nancy E Mayo4.   

Abstract

BACKGROUND: Heterogeneity in disease course exists within multiple sclerosis (MS) subtypes.
OBJECTIVE: The objective was to estimate disease course heterogeneity over three distinct onset periods (pre-1995, 1995-2004, and 2005-present) for men and women.
METHODS: Group-based trajectory model (GBTM) was used to estimate clusters of patients following stable or unstable disease progression trajectories based on the Expanded Disability Status Scale (EDSS). Inception cohorts were generated from the Montreal Neurological Institute MS Clinic registry. Stable trajectories were defined as an EDSS ⩽3.0 and change ⩽1 point over the study period. Annualized relapse rate (ARR) based on the first 5 years of disease was an explanatory variable.
RESULTS: Proportion of women classified as stable was 0% for pre-1995, 69.0% for 1995-2004, and 83.9% post-2005; for men, these proportions were 18.4%, 41.4%, and 53.8%, respectively. Men had lower percentage of stable disease than women in both post-1995 cohorts (chi-square p < 0.0001). ARR was associated with higher disability trajectories in both post-1995 cohort (odds ratios >1.0) but not in the pre-1995 cohort.
CONCLUSION: Large proportions of patients remain stable at their initial disability level for at least 15 years. Higher ARR increases the odds of patients being in a higher disability trajectory in the latter cohorts.

Entities:  

Keywords:  Multiple sclerosis; disease course; epidemiology

Mesh:

Year:  2016        PMID: 27364326     DOI: 10.1177/1352458516655478

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  8 in total

1.  Delirium Severity Trajectories and Outcomes in ICU Patients. Defining a Dynamic Symptom Phenotype.

Authors:  Heidi Lindroth; Babar A Khan; Janet S Carpenter; Sujuan Gao; Anthony J Perkins; Sikandar H Khan; Sophia Wang; Richard N Jones; Malaz A Boustani
Journal:  Ann Am Thorac Soc       Date:  2020-09

2.  Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy.

Authors:  Lorena Lorefice; Federica Murgia; Giuseppe Fenu; Jessica Frau; Giancarlo Coghe; Maria Rita Murru; Stefania Tranquilli; Andrea Visconti; Maria Giovanna Marrosu; Luigi Atzori; Eleonora Cocco
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 3.  Correlation of geographic distributions of haptoglobin alleles with prevalence of multiple sclerosis (MS) - a narrative literature review.

Authors:  Vladimir V Bamm; Arielle M Geist; George Harauz
Journal:  Metab Brain Dis       Date:  2016-11-02       Impact factor: 3.584

4.  Physical and Mental Health-Related Quality of Life Trajectories Among People With Multiple Sclerosis.

Authors:  Julia O'Mahony; Amber Salter; Beyza Ciftci; Robert J Fox; Gary R Cutter; Ruth Ann Marrie
Journal:  Neurology       Date:  2022-08-10       Impact factor: 11.800

5.  Does group-based trajectory modeling estimate spurious trajectories?

Authors:  Miceline Mésidor; Marie-Claude Rousseau; Jennifer O'Loughlin; Marie-Pierre Sylvestre
Journal:  BMC Med Res Methodol       Date:  2022-07-14       Impact factor: 4.612

6.  Long-term worsening of different body functions in persons with progressive multiple sclerosis.

Authors:  Marco Kaufmann; Claude Vaney; Laura Barin; Xinglu Liu; Viktor von Wyl
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-10-13

7.  Outcomes in a Modern Cohort of Treated Patients with Multiple Sclerosis from Diagnosis Up to 15 Years.

Authors:  Thomas F Scott; Troy Desai; Chris Hackett; Edward J Gettings; Teresa Hentosz; Wisam Elmalik; Carol J Schramke
Journal:  Int J MS Care       Date:  2019-12-05

8.  Static and group-based trajectory analyses of factors associated with non-adherence in patients with multiple sclerosis newly-initiating once- or twice-daily oral disease-modifying therapy.

Authors:  Jacqueline A Nicholas; Natalie C Edwards; Roger A Edwards; Anna Dellarole; Luigi Manca; Danielle E Harlow; Amy L Phillips
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.